Q

uniQure NV
D

QURE

8.95000
USD
-0.78
(-8.02%)
مغلق
حجم التداول
79,179
الربح لكل سهم
-3
العائد الربحي
-
P/E
-2
حجم السوق
483,988,076
أصول ذات صلة
B
BLUE
0.06000
(1.23%)
4.94000 USD
C
CLLS
-0.08000
(-6.56%)
1.14000 USD
C
CRSP
0.000
(0.00%)
32.650 USD
E
EDIT
-0.08500
(-7.59%)
1.03500 USD
F
FATE
0.07220
(10.46%)
0.76230 USD
N
NTLA
-0.26500
(-3.85%)
6.62000 USD
R
RCKT
-0.45000
(-8.10%)
5.10500 USD
S
SGMO
0.03970
(6.40%)
0.65980 USD
V
VYGR
-0.01500
(-0.48%)
3.09000 USD
المزيد
الأخبار المقالات

العنوان: uniQure NV

القطاع: Healthcare
الصناعة: Biotechnology
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.